👤 Huili Jiang

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
873
Articles
597
Name variants
Also published as: Aimin Jiang, Anan Jiang, Bao Jiang, Baoping Jiang, Bei Jiang, Bin Jiang, Bing-Hua Jiang, Bingdong Jiang, Bo Jiang, Bowen Jiang, Caiyun Jiang, Can Jiang, Cen Jiang, Changtao Jiang, Chao Jiang, Chao Qiang Jiang, Chaoqian Jiang, Chaoqiang Jiang, Charlie Jiang, Chen Jiang, Chen-Chen Jiang, Chen-Yang Jiang, Cheng Jiang, Cheng-Yan Jiang, Chengxian Jiang, Chengzhi Jiang, Chenke Jiang, Chenyang Jiang, Chongyi Jiang, Chuanhe Jiang, Chun-Guo Jiang, Chun-Lei Jiang, Chunhui Jiang, Chunmiao Jiang, Chunping Jiang, Chunqing Jiang, Chunyang Jiang, Congqing Jiang, Cui-Ping Jiang, Cuihua Jiang, Cuiping Jiang, Da Jiang, Dahai Jiang, Dan Jiang, Dandan Jiang, Danjie Jiang, Dawei Jiang, Deke Jiang, Dong Jiang, Dong-Neng Jiang, Dongmei Jiang, Dongsheng Jiang, Dongwen Jiang, Dongyang Jiang, F Jiang, Fan Jiang, Fang Jiang, Fangqin Jiang, Fei Jiang, Feng Jiang, Fengjuan Jiang, Fengli Jiang, Fengqi Jiang, Fengxian Jiang, Fengze Jiang, Fu-Sheng Jiang, Fuling Jiang, Gang Jiang, Gaowei Jiang, Gening Jiang, Guan-Min Jiang, Guang Jiang, Guang-Jian Jiang, Guanglong Jiang, Guangpeng Jiang, Guangyu Jiang, Guangzhen Jiang, Guannan Jiang, Gui-Yang Jiang, Guitao Jiang, Guiya Jiang, Guiyang Jiang, Guli Jiang, Guoheng Jiang, Guoliang Jiang, Guoqiang Jiang, Guoyan Jiang, Guozhi Jiang, H Jiang, Hai-He Jiang, Hai-Lu Jiang, Hai-Lun Jiang, Hai-ou Jiang, Haibo Jiang, Haifang Jiang, Haifeng Jiang, Haijun Jiang, Hailun Jiang, Haiping Jiang, Haiqiang Jiang, Haisong Jiang, Haixing Jiang, Haiyang Jiang, Haiying Jiang, Haizhen Jiang, Han Jiang, Han-Tao Jiang, Hanjie Jiang, Hanxue Jiang, Hao Jiang, Haowen Jiang, He Jiang, Hemin Jiang, Hequn Jiang, Hong Jiang, Hong-Li Jiang, Hong-Yan Jiang, Hong-liu Jiang, Hongcheng Jiang, Hongchi Jiang, Hongjing Jiang, Hongkun Jiang, Hongli Jiang, Hongxiang Jiang, Hongyu Jiang, Houbo Jiang, Hu Jiang, Hua Jiang, Huajun Jiang, Hualiang Jiang, Huanglei Jiang, Huanguo Jiang, Huanyu Jiang, Huanzhu Jiang, Huawei Jiang, Hugang Jiang, Hui Jiang, Hui-Hui Jiang, Huiqing Jiang, Huiyong Jiang, J Jiang, Jessica Li Jiang, Ji Jiang, Ji-yao Jiang, Jia Jiang, Jiahao Jiang, Jiahong Jiang, Jian Jiang, Jian-Dong Jiang, Jian-Gang Jiang, Jianan Jiang, Jiandong Jiang, Jianhua Jiang, Jianhui Jiang, Jianming Jiang, Jianrong Jiang, Jiansen Jiang, Jianwei Jiang, Jiaqi Jiang, Jiawei Jiang, Jiaxuan Jiang, Jie Jiang, Jie-Feng Jiang, Jieqing Jiang, Jieyi Jiang, Jiji Jiang, Jin Jiang, Jin-Yan Jiang, Jinfeng Jiang, Jing Jiang, Jing-Si Jiang, Jingbo Jiang, Jinghua Jiang, Jingjing Jiang, Jingwei Jiang, Jingwen Jiang, Jingyan Jiang, Jingzhou Jiang, Jinhong Jiang, Jinhua Jiang, Jinlan Jiang, Jinlun Jiang, Jinxia Jiang, Jinyun Jiang, Jishun Jiang, Jiwei Jiang, Jiyang Jiang, Jiyue Jiang, Jun Jiang, Jun-Jie Jiang, Junfang Jiang, K Jiang, Kai Jiang, Kang Jiang, Ke Jiang, Kele Jiang, Kuan Jiang, Kunyin Jiang, Kuo-Ching Jiang, L Jiang, Lai Jiang, Lan Jiang, Lan-Lan Jiang, Lei Jiang, Li Jiang, Li-Dan Jiang, Li-He Jiang, Li-Hong Jiang, Li-Rong Jiang, Li-Sha Jiang, Lianguang Jiang, Lianyong Jiang, Lihong Jiang, Lihuan Jiang, Lijing Jiang, Lijuan Jiang, Lijun Jiang, Lili Jiang, Lin Jiang, Ling Jiang, Ling-Xiang Jiang, Lingli Jiang, Linglin Jiang, Lingling Jiang, Linke Jiang, Linlin Jiang, Linying Jiang, Liping Jiang, Liqing Jiang, Lishi Jiang, Liuyan Jiang, Lixin Jiang, Liying Jiang, Long Jiang, Longying Jiang, Lu Jiang, Man Jiang, Mei Jiang, Meichen Jiang, Meichun Jiang, Meimei Jiang, Meixiu Jiang, Meng Jiang, Meng-Ting Jiang, Mengjie Jiang, Mengmeng Jiang, Mengqiang Jiang, Mengxi Jiang, Mengxue Jiang, Mengya Jiang, Mengzhu Jiang, Min Jiang, Ming Jiang, Ming-Rui Jiang, Mingchen Jiang, Minghao Jiang, Minghu Jiang, Mingshan Jiang, Mingxing Jiang, Mingyang Jiang, Minqing Jiang, Mona Zhi Ling Mai Jiang, Mouyan Jiang, Mujun Jiang, Nan Jiang, Nanying Jiang, Neng Jiang, Nengjing Jiang, Nili Jiang, Ning Jiang, Ou Jiang, Pan Jiang, Pan-Qiang Jiang, Pei Jiang, Peipei Jiang, Peng Jiang, Pengling Jiang, Ping Jiang, Ping-Ping Jiang, Pu Jiang, Qi Jiang, Qi-Chen Jiang, Qian Jiang, Qiang Jiang, Qianzhu Jiang, Qichen Jiang, Qicheng Jiang, Qin Jiang, Qing Jiang, Qing-Wu Jiang, Qing-Yan Jiang, Qinghua Jiang, Qingkun Jiang, Qingping Jiang, Qinyang Jiang, Qiu Jiang, Qiu-Le Jiang, Qiuxiao Jiang, Qiuyan Jiang, Qiwei Jiang, Qixia Jiang, Renjun Jiang, Rong Jiang, Rongqi Jiang, Rongtao Jiang, Rongyan Jiang, Roulan Jiang, Ru-Chao Jiang, Ruirui Jiang, Ruiwei Jiang, Rulang Jiang, Runqiu Jiang, Runshen Jiang, Runyang Jiang, S Q Jiang, Shali Jiang, Shan Jiang, Shan-Shan Jiang, Shanfeng Jiang, Shanshan Jiang, Shantong Jiang, Shaokai Jiang, Shaoping Jiang, Shaowen Jiang, Shaoxiong Jiang, Sharon Jiang, Sheng Jiang, Shengnan Jiang, Shengwang Jiang, Shengying Jiang, Shi Jiang, Shih Sheng Jiang, ShihSheng Jiang, Shimin Jiang, Shiqing Jiang, Shirui Jiang, Shiwen Jiang, Shou-Yin Jiang, Shoufang Jiang, Shoulei Jiang, Shouwen Jiang, Shu Jiang, Shu-Zhen Jiang, Shuai Jiang, Shuang Jiang, Shusuan Jiang, Shuying Jiang, Shuzhong Jiang, Si-Liang Jiang, Sicong Jiang, Simon W Jiang, Sixiong Jiang, Siyi Jiang, Siyu Jiang, Songhao Jiang, Su Jiang, Sujun Jiang, Susu Jiang, Suyu Jiang, T Jiang, Tao Jiang, Tengfei Jiang, Tengyong Jiang, Tian Jiang, Tianlin Jiang, Tianqi Jiang, Tianyu Jiang, Ting Jiang, Ting-Bo Jiang, Ting-Ting Jiang, Ting-Wang Jiang, Tingbo Jiang, Tingting Jiang, Tingyun Jiang, Tongcui Jiang, W Jiang, Wan-Sheng Jiang, Wangjie Jiang, Wanqing Jiang, Wei I Jiang, Wei Jiang, Wei-Cheng Jiang, Weibo Jiang, Weifan Jiang, Weihao Jiang, Weijun Jiang, Weimin Jiang, Weiqi Jiang, Weixi Jiang, Wen G Jiang, Wen Jiang, Wen-Hua Jiang, Wen-Ping Jiang, Wen-Qi Jiang, Wen-hui Jiang, Wencan Jiang, Wenjuan Jiang, Wenna Jiang, Wenqing Jiang, Wenrong Jiang, Wenyi Jiang, X Jiang, X L Jiang, Xia Jiang, Xian-Cheng Jiang, Xiang Jiang, Xiang-Jun Jiang, Xiangjun Jiang, Xiangning Jiang, Xianta Jiang, Xiao Jiang, Xiao-Cui Jiang, Xiao-Lan Jiang, Xiao-Wen Jiang, Xiao-dan Jiang, Xiaobing Jiang, Xiaocong Jiang, Xiaofei Jiang, Xiaofeng Jiang, Xiaohua Jiang, Xiaohui Jiang, Xiaojuan Jiang, Xiaoli Jiang, Xiaolin Jiang, Xiaolu Jiang, Xiaomin Jiang, Xiaona Jiang, Xiaosong Jiang, Xiaotao Jiang, Xiaoting Jiang, Xiaowen Jiang, Xiaoxiao Jiang, Xiaoxue Jiang, Xiaoyan Jiang, Xiaoyi Jiang, Xiaoyu Jiang, Xihong Jiang, Xijing Jiang, Xin Jiang, Xinfeng Jiang, Xing Jiang, Xinghong Jiang, Xinglin Jiang, Xinhai Jiang, Xinlong Jiang, Xinwei Jiang, Xinyi Jiang, Xinyin Jiang, Xinyue Jiang, Xiong Jiang, Xiufeng Jiang, Xiulong Jiang, Xuanting Jiang, Xue Jiang, Xuejun Jiang, Xueli Jiang, Xuemei Jiang, Xueping Jiang, Xueqin Jiang, Xuexia Jiang, Xueying Jiang, Xuhong Jiang, Xun Jiang, Xunping Jiang, Xunwei Jiang, Y Jiang, Y-D Jiang, Ya-Ping Jiang, Yafei Jiang, Yali Jiang, Yamei Jiang, Yan Jiang, Yan-Yi Jiang, Yanan Jiang, Yanchao Jiang, Yanfang Jiang, Yanfeng Jiang, Yang Jiang, Yangfu Jiang, Yangyang Jiang, Yanji Jiang, Yanle Jiang, Yanming Jiang, Yanping Jiang, Yanshuang Jiang, Yanxin Jiang, Yanyan Jiang, Yanzhi Jiang, Yaofei Jiang, Yaona Jiang, Yaxi Jiang, Yazhuo Jiang, Yexiang Jiang, Yi Jiang, Yi-Xue Jiang, Yiao Jiang, Yida Jiang, Yilin Jiang, Yinan Jiang, Ying Jiang, Ying-Ming Jiang, Yingjie Jiang, Yingsong Jiang, Yingying Jiang, Yinhui Jiang, Yiran Jiang, Yiting Jiang, Yitong Jiang, Yong Fang Jiang, Yong Jiang, Yong-Li Jiang, Yong-Qing Jiang, Yong-Sheng Jiang, Yonghong Jiang, Yonghui Jiang, Yongliang Jiang, Yongpo Jiang, Yongqing Jiang, You-Hua Jiang, Youde Jiang, Youhai Jiang, Youming Jiang, Yu Jiang, Yu-Hang Jiang, Yu-Jia Jiang, Yu-Lin Jiang, Yu-Xuan Jiang, Yu-ping Jiang, Yuan Jiang, Yuanjun Jiang, Yuanyuan Jiang, Yue Jiang, Yue-Ming Jiang, Yue-Ping Jiang, Yuecheng Jiang, Yueping Jiang, Yuer Jiang, Yufeng Jiang, Yuhan Jiang, Yuhang Jiang, Yuhui Jiang, Yumin Jiang, Yun-Jin Jiang, Yunjing Jiang, Yunliang Jiang, Yunsheng Jiang, Yunxiu Jiang, Yunzhe Jiang, Yupeng Jiang, Yutao Jiang, Yuteng Jiang, Yuting Jiang, Yuwei Jiang, Yuwu Jiang, Z Gordon Jiang, Z Jiang, Z Y Jiang, Z-Y Jiang, Ze-Bin Jiang, Zesong Jiang, Zetan Jiang, Zeyu Jiang, Zhao Jiang, Zhao-Yan Jiang, Zhaodi Jiang, Zhaoshi Jiang, Zhen Jiang, Zheng Jiang, Zheng-Yuan Jiang, Zhengfan Jiang, Zhenghui G Jiang, Zhengming Jiang, Zhengqiao Jiang, Zhengwen Jiang, Zhengwu Jiang, Zhengxuan Jiang, Zhengyi Jiang, Zhentao Jiang, Zhi-Sheng Jiang, Zhi-Yan Jiang, Zhi-Ying Jiang, Zhichao Jiang, Zhicong Jiang, Zhiwei Jiang, Zhixia Jiang, Zhixin Jiang, Zhiying Jiang, Zhongshan Jiang, Zi-Hua Jiang, Zichao Jiang, Zipei Jiang, Ziqin Jiang, Ziyi Jiang, Ziying Jiang, Ziyu Jiang, Zong-Zhe Jiang
articles
Ze Xiang, Bin Jiang, Wei Li +4 more · 2022 · Journal of medical virology · Wiley · added 2026-04-24
Early diagnosis and prognosis evaluation are of great significance to hepatitis E virus (HEV)-related acute liver failure (HEV-ALF) patients. We collected serum samples from 200 health controls (HCs), Show more
Early diagnosis and prognosis evaluation are of great significance to hepatitis E virus (HEV)-related acute liver failure (HEV-ALF) patients. We collected serum samples from 200 health controls (HCs), 200 patients with acute hepatitis E (AHE), and 200 HEV-ALF patients to evaluate serum exosome-derived carbamoyl phosphate synthase 1 (CPS1) levels and determine its diagnostic and prognostic value. The exosome-derived CPS1 levels in the HEV-ALF group were significantly higher than those in the AHE and HCs groups. The AUC of exosome-derived CPS1 to predict the occurrence of HEV-ALF was 0.850 (0.811-0.883). Both logistical regression and orthogonal partial least squares discriminant analysis (OPLS-DA) showed that exosome-derived CPS1 is an independent risk factor for HEV-ALF. The exosome-derived CPS1 levels were positively correlated with organ failure and the outcomes in HEV-ALF patients. The exosome-derived CPS1 levels in the worsening group were significantly higher than those in the fluctuating and the improving groups. The AUC of serum exosome-derived CPS1 to predict 30-day mortality was 0.829 (0.770-0.879), which was significantly greater than that of the Child-Pugh, KCH, and MELD models. The level of serum exosome-derived CPS1 might serve as a promising diagnostic and prognostic biomarker for HEV-ALF patients, which may provide better guidance for the diagnosis, prognosis, and treatment of HEV-ALF patients. Show less
no PDF DOI: 10.1002/jmv.27961
CPS1
Shu-Meng Ren, Qing-Zhu Zhang, Man Jiang +5 more · 2022 · Journal of ethnopharmacology · Elsevier · added 2026-04-24
Walnut kernel, a well-known TCM, is often used after being defatted in tradition. And defatted walnut powder extract (DWPE) has the actions of tonifying the liver and kidney, dissipating stagnation an Show more
Walnut kernel, a well-known TCM, is often used after being defatted in tradition. And defatted walnut powder extract (DWPE) has the actions of tonifying the liver and kidney, dissipating stagnation and removing blood stasis, which has the effect on non-alcoholic fatty liver disease (NAFLD). However, the effective components of DWPE in vivo were unclear and the multiple mechanisms of DWPE against NAFLD have not been explored. The studies were performed to screen the effective substances in vivo by identification of the metabolites of DWPE in rats and to seek the potential mechanisms of DWPE on NAFLD by construction of the network pharmacology based on metabolites and verification of the highly correlated pathway. To explore the effective substances in vivo, the metabolites of DWPE were identified in SD rats' bio-samples through UPLC-Q-Exactive Orbitrap MS. To analyze the mechanisms of DWPE on NAFLD, a Metabolite-Target-Disease network was established and the potential mechanisms were predicted. Then, highly correlated pathway was verified in animal and cells studies. A total of 52 metabolites of DWPE were identified in vivo, which were derived from gallic acid, ellagic acid (EA) and glansreginin A (Gla A). The possible metabolic pathways were phase Ⅰ (hydroxylation, hydrolyzation, etc) and phase Ⅱ metabolic reactions (methylation, sulfation and glucuronidation). Furthermore, in the network pharmacology, 54 core targets were enriched into pathways in cancer, nitrogen metabolism and other 9 pathways, which were essential pathways of DWPE against NAFLD. And the mechanism of nitrogen metabolism was verified in both of animal and cells studies. The results showed that DWPE could decline the concentration of ammonia and increase the expressions of carbonic anhydrase 2 (CA2) and carbamoylphosphate synthetase (CPS1) in nitrogen metabolism. Taken together, the study revealed the absorption components and their metabolic pathways and demonstrated the mechanism of nitrogen metabolism of DWPE on anti-NAFLD. Show less
no PDF DOI: 10.1016/j.jep.2021.114870
CPS1
Xinyi Huang, Ke Zhao, Mingyang Jiang +3 more · 2022 · The Journal of biological chemistry · Elsevier · added 2026-04-24
The G-quadruplex (G4) resolvase RNA helicase associated with AU-rich element (RHAU) possesses the ability to unwind G4 structures in both DNA and RNA molecules. Previously, we revealed that RHAU plays Show more
The G-quadruplex (G4) resolvase RNA helicase associated with AU-rich element (RHAU) possesses the ability to unwind G4 structures in both DNA and RNA molecules. Previously, we revealed that RHAU plays a critical role in embryonic heart development and postnatal heart function through modulating mRNA translation and stability. However, whether RHAU functions to resolve DNA G4 in the regulation of cardiac physiology is still elusive. Here, we identified a phenotype of noncompaction cardiomyopathy in cardiomyocyte-specific Rhau deletion mice, including such symptoms as spongiform cardiomyopathy, heart dilation, and death at young ages. We also observed reduced cardiomyocyte proliferation and advanced sarcomere maturation in Rhau mutant mice. Further studies demonstrated that RHAU regulates the expression levels of several genes associated with ventricular trabeculation and compaction, including the Nkx2-5 and Hey2 that encode cardiac transcription factors of NKX2-5 and Hey2, and the myosin heavy chain 7 (Myh7) whose protein product is MYH7. While RHAU modulates Nkx2-5 mRNA and Hey2 mRNA at the post-transcriptional level, we uncovered that RHAU facilitates the transcription of Myh7 through unwinding of the G4 structures in its promoter. These findings demonstrated that RHAU regulates ventricular chamber development through both transcriptional and post-transcriptional mechanisms. These results contribute to a knowledge base that will help to understand the pathogenesis of diseases such as noncompaction cardiomyopathy. Show less
📄 PDF DOI: 10.1016/j.jbc.2021.101449
DHX36
Xiaohai Zhou, Chenyang Zhang, Xueying Wu +15 more · 2022 · Nature communications · Nature · added 2026-04-24
Dual-specificity phosphatase 6 (DUSP6) serves a specific and conserved function on the dephosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2). We previously identified Dusp6 as a rege Show more
Dual-specificity phosphatase 6 (DUSP6) serves a specific and conserved function on the dephosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2). We previously identified Dusp6 as a regenerative repressor during zebrafish heart regeneration, therefore we propose to investigate the role of this repressor in mammalian cardiac repair. Utilizing a rat strain harboring Dusp6 nonsense mutation, rat neutrophil-cardiomyocyte co-culture, bone marrow transplanted rats and neutrophil-specific Dusp6 knockout mice, we find that Dusp6 deficiency improves cardiac outcomes by predominantly attenuating neutrophil-mediated myocardial damage in acute inflammatory phase after myocardial infarction. Mechanistically, Dusp6 is transcriptionally activated by p38-C/EBPβ signaling and acts as an effector for maintaining p-p38 activity by down-regulating pERK and p38-targeting phosphatases DUSP1/DUSP16. Our findings provide robust animal models and novel insights for neutrophil-mediated cardiac damage and demonstrate the potential of DUSP6 as a therapeutic target for post-MI cardiac remodeling and other relevant inflammatory diseases. Show less
📄 PDF DOI: 10.1038/s41467-022-33631-z
DUSP6
Fangdie Ye, Yingchun Liang, Zhang Cheng +6 more · 2022 · Frontiers in immunology · Frontiers · added 2026-04-24
Several studies have found that pathological imbalance of alterative splicing (AS) events is associated with cancer susceptibility. carcinogenicity. Nevertheless, the relationship between heritable va Show more
Several studies have found that pathological imbalance of alterative splicing (AS) events is associated with cancer susceptibility. carcinogenicity. Nevertheless, the relationship between heritable variation in AS events and carcinogenicity has not been extensively explored. Here, we downloaded AS event signatures, transcriptome profiles, and matched clinical information from The Cancer Genome Atlas (TCGA) database, identified the prognostic AS-related events Show less
📄 PDF DOI: 10.3389/fimmu.2022.911902
DYM
Hong Xu, Yuhang Li, Yanan Jiang +9 more · 2022 · Frontiers in genetics · Frontiers · added 2026-04-24
📄 PDF DOI: 10.3389/fgene.2022.827840
EXT1
S Kimura, N Takeshita, T Oyanagi +6 more · 2022 · Journal of dental research · SAGE Publications · added 2026-04-24
Enamel is the highly mineralized outer layer of teeth; the cells responsible for enamel formation are ameloblasts. Local hypoxia and hypoxia inducible factor (HIF) in embryonic tissues are important t Show more
Enamel is the highly mineralized outer layer of teeth; the cells responsible for enamel formation are ameloblasts. Local hypoxia and hypoxia inducible factor (HIF) in embryonic tissues are important to promote normal organogenesis. However, hypoxic state in tooth germs and the roles of HIF in ameloblast differentiation have not been understood. The aim of this study is to clarify the role of HIF in ameloblast differentiation during tooth germ development. We found that tooth germs were under hypoxia and HIF-1α and HIF-2α were expressed in tooth germs in embryonic mice. Then, we used HIF inhibitors to evaluate the function of HIF during tooth germ development. The HIF-2α inhibitor significantly decreased the size of tooth germs in organ culture, while the HIF-1α inhibitor did not apparently affect the size of tooth germs. The HIF-2α inhibitor enhanced the expression of amelogenin, a marker of ameloblast differentiation, in the tooth germs in organ culture and rat dental epithelial SF2 cells. Moreover, we found that the HIF-2α inhibitor-stimulating amelogenin expression was regulated by hes-related family basic helix-loop-helix transcription factor with YRPW motif 2(Hey2) in SF2 cells. These findings suggest that the HIF-2α-Hey2 axis plays an important role in ameloblast differentiation during tooth germ development. Show less
no PDF DOI: 10.1177/00220345221111971
HEY2
Tiantian Gu, Mingcai Duan, Ruikun Zhang +7 more · 2022 · Frontiers in microbiology · Frontiers · added 2026-04-24
The aim of this study was to investigate the effects of different probiotic fermented feed (PFF) on ameliorating liver fat accumulation by modulating the gut microbiota. A total of 216, 120-day-old Sh Show more
The aim of this study was to investigate the effects of different probiotic fermented feed (PFF) on ameliorating liver fat accumulation by modulating the gut microbiota. A total of 216, 120-day-old Shaoxing ducks were divided into three groups, including the control group (basal diet), or the basal diet supplemented with 25 or 35% PFF. The results of the animal experiment showed that supplementation with PFF markedly alleviated the formation of liver and abdominal lipid droplet and decreased the levels of serum triglyceride (TG) in Shaoxing ducks. 16s rDNA showed that PFF could modulate the composition of gut microbiota, in particular, modulating the ratio of Firmicutes to Bacteroidetes. Moreover, PFF restructures the gut microbiome by reducing the abundance of Ruminococcaceae, Lachnospiraceae, and Prevotellaceae in ducks. Additionally, liver transcriptome analysis indicated that the PFF supplementation significantly downregulated the mRNA expression of peroxisome proliferator-activated receptor gamma Show less
📄 PDF DOI: 10.3389/fmicb.2022.928670
HSD17B12
Jiameng Lu, Xiaoqing Ji, Lixia Wang +8 more · 2022 · International journal of molecular medicine · added 2026-04-24
Interleukin (IL)‑27 can inhibit the differentiation of Th2 cells and plays a role in the development of asthma. However, whether the therapeutic administration of IL‑27 in a mouse model of asthma can Show more
Interleukin (IL)‑27 can inhibit the differentiation of Th2 cells and plays a role in the development of asthma. However, whether the therapeutic administration of IL‑27 in a mouse model of asthma can inhibit allergic responses remains a matter of debate. Additionally, the mechanisms through which IL‑27 ameliorates inflammatory responses in asthma are not yet fully understood. Thus, the aim of the present study was to examine the effects of IL‑27 on asthma using a mouse model and to elucidate the underlying mechanisms. For this purpose, mice received an intranasal administration of IL‑27 and the total and differential cell counts, levels of cytokines and type 1 regulatory T (Tr1) cells in the lungs were detected. The protein and mRNA levels of signal transducer and activator of transcription (STAT)1 and STAT3 were analyzed and airway remodeling was assessed. The results indicated that IL‑27 did not ameliorate airway inflammation, airway hyperresponsiveness, and airway remolding when administrated therapeutically. Preventatively, the administration of IL‑27 decreased the concentrations of Th2 cytokines and increased the number of Tr1 cells. The protein and mRNA levels of STAT1 and STAT3 were increased. Taken together, these findings demonstrate that the prophylactic administration of IL‑27 ameliorates asthma by alleviating the lung Th2 inflammatory environment through the restoration of both the STAT1 and STAT3 pathways. IL‑27 may thus prove to be useful as a novel agent for the prevention of asthma. Show less
📄 PDF DOI: 10.3892/ijmm.2022.5142
IL27
Xiaopeng Wan, Yuanyuan Zhang, Huanna Tang +10 more · 2022 · Journal of leukocyte biology · Wiley · added 2026-04-24
IL-27 is a member of the IL-12 family, exerting both anti- and pro-inflammatory activity in a cell-dependent and disease context-specific manner. Antigen-mediated cross-linking of IgE on mast cells tr Show more
IL-27 is a member of the IL-12 family, exerting both anti- and pro-inflammatory activity in a cell-dependent and disease context-specific manner. Antigen-mediated cross-linking of IgE on mast cells triggers a signaling cascade that results in mast cell degranulation and proinflammatory cytokine production, which are key effectors in allergic reactions. Here, we show that the activation of mast cells is negatively regulated by IL-27 signaling. We found that mice lacking IL-27Rα (WSX-1) displayed increased sensitivity to IgE-mediated skin allergic response and chronic airway inflammation. The bone marrow-derived mast cells (BMMCs) of IL-27Rα-deficient mouse showed greater high-affinity receptor Fc epsilon RI (FcεRI)-mediated activation with significantly enhanced degranulation and cytokine production. Mechanistically, the dysregulated signaling in IL-27Rα Show less
no PDF DOI: 10.1002/JLB.2MA1221-637R
IL27
Hao Yang, Lin Jiang, Yi Zhang +13 more · 2022 · The Journal of comparative neurology · Wiley · added 2026-04-24
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (LINGO-1), a negative regulator of oligodendrocyte differentiation and myelination, is associated with Show more
Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (LINGO-1), a negative regulator of oligodendrocyte differentiation and myelination, is associated with cognitive function, and its expression is highly upregulated in Alzheimer's disease (AD) patients. Anti-LINGO-1 antibody treatment can effectively antagonize the negative regulatory effect of LINGO-1. In this study, we aim to assess the effect of anti-LINGO-1 antibody treatment on cognition and hippocampal oligodendrocytes in an AD transgenic animal model. First, 10-month-old male amyloid-β (Aβ) protein precursor (APP)/presenilin 1 (PS1) mice were administered anti-LINGO-1 antibody for 8 weeks. Then, learning and memory abilities were assessed with the Morris water maze (MWM) and Y-maze tests, and Aβ deposition and hippocampal oligodendrocytes were investigated by immunohistochemistry, immunofluorescence, and stereology. We found that anti-LINGO-1 antibody alleviated the deficits in spatial learning and memory abilities and working and reference memory abilities, decreased the density of LINGO-1 positive cells, decreased Aβ deposition, significantly increased the number of mature oligodendrocytes and the density of myelin, reversed the abnormal increases in the number of oligodendrocyte lineage cells and the densities of oligodendrocytes precursor cells in APP/PS1 mice. Our results provide evidence that LINGO-1 might be involved in the process of oligodendrocyte dysmaturity in the hippocampus of AD mice, and that antagonizing LINGO-1 can alleviate cognitive deficits in APP/PS1 mice and decrease Aβ deposition and promote oligodendrocyte differentiation and maturation in the hippocampus of these mice. Our findings suggest that changes in LINGO-1 and oligodendrocytes in the hippocampus play important roles in the pathogenesis of AD and that antagonizing LINGO-1 might be a potential therapeutic strategy for AD. Show less
no PDF DOI: 10.1002/cne.25299
LINGO1
Shanfeng Jiang, Chong Yin, Kai Dang +3 more · 2022 · BMC genomics · BioMed Central · added 2026-04-24
Previous studies have shown that microtubule actin crosslinking factor 1 (MACF1) can regulate osteoblast proliferation and differentiation through non-coding RNA (ncRNA) in bone-forming osteoblasts. H Show more
Previous studies have shown that microtubule actin crosslinking factor 1 (MACF1) can regulate osteoblast proliferation and differentiation through non-coding RNA (ncRNA) in bone-forming osteoblasts. However, the role of MACF1 in targeting the competing endogenous RNA (ceRNA) network to regulate osteoblast differentiation remains poorly understood. Here, we profiled messenger RNA (mRNA), microRNA (miRNA), and long ncRNA (lncRNA) expression in MACF1 knockdown MC3TC‑E1 pre‑osteoblast cells. In total, 547 lncRNAs, 107 miRNAs, and 376 mRNAs were differentially expressed. Significantly altered lncRNAs, miRNAs, and mRNAs were primarily found on chromosome 2. A lncRNA-miRNA-mRNA network was constructed using a bioinformatics computational approach. The network indicated that mir-7063 and mir-7646 were the most potent ncRNA regulators and mef2c was the most potent target gene. Pathway enrichment analysis showed that the fluid shear stress and atherosclerosis, p53 signaling, and focal adhesion pathways were highly enriched and contributed to osteoblast proliferation. Importantly, the fluid shear stress and atherosclerosis pathway was co-regulated by lncRNAs and miRNAs. In this pathway, Dusp1 was regulated by AK079370, while Arhgef2 was regulated by mir-5101. Furthermore, Map3k5 was regulated by AK154638 and mir-466q simultaneously. AK003142 and mir-3082-5p as well as Ak141402 and mir-446 m-3p were identified as interacting pairs that regulate target genes. This study revealed the global expression profile of ceRNAs involved in the differentiation of MC3TC‑E1 osteoblasts induced by MACF1 deletion. These results indicate that loss of MACF1 activates a comprehensive ceRNA network to regulate osteoblast proliferation. Show less
📄 PDF DOI: 10.1186/s12864-022-08910-0
MACF1
Yaodong Zhang, Zijian Ma, Changxian Li +15 more · 2022 · Nature communications · Nature · added 2026-04-24
Molecular variation between geographical populations and subtypes indicate potential genomic heterogeneity and novel genomic features within CCA. Here, we analyze exome-sequencing data of 87 perihilar Show more
Molecular variation between geographical populations and subtypes indicate potential genomic heterogeneity and novel genomic features within CCA. Here, we analyze exome-sequencing data of 87 perihilar cholangiocarcinoma (pCCA) and 261 intrahepatic cholangiocarcinoma (iCCA) cases from 3 Asian centers (including 43 pCCAs and 24 iCCAs from our center). iCCA tumours demonstrate a higher tumor mutation burden and copy number alteration burden (CNAB) than pCCA tumours, and high CNAB indicates a poorer pCCA prognosis. We identify 12 significantly mutated genes and 5 focal CNA regions, and demonstrate common mutations in post-transcriptional modification-related potential driver genes METTL14 and RBM10 in pCCA tumours. Finally we demonstrate the tumour-suppressive role of METTL14, a major RNA N6-adenosine methyltransferase (m6A), and illustrate that its loss-of-function mutation R298H may act through m6A modification on potential driver gene MACF1. Our results may be valuable for better understanding of how post-transcriptional modification can affect CCA development, and highlight both similarities and differences between pCCA and iCCA. Show less
📄 PDF DOI: 10.1038/s41467-022-30708-7
MACF1
Tao Zhou, Yaodong Zhang, Yananlan Chen +11 more · 2022 · Frontiers in oncology · Frontiers · added 2026-04-24
Cholangiocarcinoma (CCA) remains one of the most lethal malignancies with an increasing incidence globally. Through whole-exome sequencing of 67 CCA tissues, we identified new mutated genes in CCA, in Show more
Cholangiocarcinoma (CCA) remains one of the most lethal malignancies with an increasing incidence globally. Through whole-exome sequencing of 67 CCA tissues, we identified new mutated genes in CCA, including MACF1, METTL14, ROBO1, and so on. The study was designed to explore the effects and mechanism of ROBO1 wild type (ROBO1 Whole-exome sequencing was performed to identify novel mutations in CCAs. Through whole-exome sequencing, we identified a novel CCA-related mutation, ROBO1 These results suggest that ROBO1 may act as a tumor suppressor and potential prognostic marker for CCA. ROBO1 Show less
📄 PDF DOI: 10.3389/fonc.2022.879963
MACF1
Yu Jiang, Travis J Meyers, Adaeze A Emeka +94 more · 2022 · HGG advances · Elsevier · added 2026-04-24
Yu Jiang, Travis J Meyers, Adaeze A Emeka, Lauren Folgosa Cooley, Phillip R Cooper, Nicola Lancki, Irene Helenowski, Linda Kachuri, Daniel W Lin, Janet L Stanford, Lisa F Newcomb, Suzanne Kolb, Antonio Finelli, Neil E Fleshner, Maria Komisarenko, James A Eastham, Behfar Ehdaie, Nicole Benfante, Christopher J Logothetis, Justin R Gregg, Cherie A Perez, Sergio Garza, Jeri Kim, Leonard S Marks, Merdie Delfin, Danielle Barsa, Danny Vesprini, Laurence H Klotz, Andrew Loblaw, Alexandre Mamedov, S Larry Goldenberg, Celestia S Higano, Maria Spillane, Eugenia Wu, H Ballentine Carter, Christian P Pavlovich, Mufaddal Mamawala, Tricia Landis, Peter R Carroll, June M Chan, Matthew R Cooperberg, Janet E Cowan, Todd M Morgan, Javed Siddiqui, Rabia Martin, Eric A Klein, Karen Brittain, Paige Gotwald, Daniel A Barocas, Jeremiah R Dallmer, Jennifer B Gordetsky, Pam Steele, Shilajit D Kundu, Jazmine Stockdale, Monique J Roobol, Lionne D F Venderbos, Martin G Sanda, Rebecca Arnold, Dattatraya Patil, Christopher P Evans, Marc A Dall'Era, Anjali Vij, Anthony J Costello, Ken Chow, Niall M Corcoran, Soroush Rais-Bahrami, Courtney Phares, Douglas S Scherr, Thomas Flynn, R Jeffrey Karnes, Michael Koch, Courtney Rose Dhondt, Joel B Nelson, Dawn McBride, Michael S Cookson, Kelly L Stratton, Stephen Farriester, Erin Hemken, Walter M Stadler, Tuula Pera, Deimante Banionyte, Fernando J Bianco, Isabel H Lopez, Stacy Loeb, Samir S Taneja, Nataliya Byrne, Christopher L Amling, Ann Martinez, Luc Boileau, Franklin D Gaylis, Jacqueline Petkewicz, Nicholas Kirwen, Brian T Helfand, Jianfeng Xu, Denise M Scholtens, William J Catalona, John S Witte Show less
Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for prosta Show more
Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for prostate cancer, many men on AS eventually convert to active treatment. PC is one of the most heritable cancers, and genetic factors that predispose to aggressive tumors may help distinguish men who are more likely to discontinue AS. To investigate this, we undertook a multi-institutional genome-wide association study (GWAS) of 5,222 PC patients and 1,139 other patients from replication cohorts, all of whom initially elected AS and were followed over time for the potential outcome of conversion from AS to active treatment. In the GWAS we detected 18 variants associated with conversion, 15 of which were not previously associated with PC risk. With a transcriptome-wide association study (TWAS), we found two genes associated with conversion ( Show less
📄 PDF DOI: 10.1016/j.xhgg.2021.100070
MAST3
Lin Jiang, Wei-Hui Zheng, Chao Chen · 2022 · Laryngoscope investigative otolaryngology · Wiley · added 2026-04-24
Carcinoma showing thymus-like elements (CASTLE) is a rare kind of malignant tumor of thyroid gland. The genetic mutation characteristics of CASTLE are not clear. We retrospectively analyzed seven pati Show more
Carcinoma showing thymus-like elements (CASTLE) is a rare kind of malignant tumor of thyroid gland. The genetic mutation characteristics of CASTLE are not clear. We retrospectively analyzed seven patients diagnosed as CASTLE tumor in our hospital, and performed whole exome sequencing (WES) in five cases to analyze the genomic variation of CASTLE in thyroid gland. The diagnosis of CASTLE was confirmed by histopathological and immunohistochemical results. Immunohistochemical staining showed that cell membranes of tumor samples in all cases were moderately to strongly positive for CD5 and CD117. WES presented a large number of single nucleotide variants (SNVs), insertions and deletions (InDel), and copy number variations (CNVs). By comparing with the TCGA database, we found novel mutations in significantly mutated genes such as CASTLE tumors contain unique tumor driver gene mutations. The information about mutations in several novel genes obtained in this study may contribute to unraveling the molecular mechanisms responsible for the emergence of thyroid CASTLE tumors and help formulating possible in-roads for treatment. Show less
📄 PDF DOI: 10.1002/lio2.805
MLLT10
Yunqiang He, Qi Fu, Min Sun +11 more · 2022 · Clinical and translational medicine · Wiley · added 2026-04-24
Acetylcholine (ACh) and norepinephrine (NE) are representative neurotransmitters of parasympathetic and sympathetic nerves, respectively, that antagonize each other to coregulate internal body functio Show more
Acetylcholine (ACh) and norepinephrine (NE) are representative neurotransmitters of parasympathetic and sympathetic nerves, respectively, that antagonize each other to coregulate internal body functions. This also includes the control of different kinds of hormone secretion from pancreatic islets. However, the molecular mechanisms have not been fully elucidated, and whether innervation in islets is abnormal in diabetes mellitus also remains unclear. Immunofluorescence colocalization and islet perfusion were performed and the results demonstrated that ACh/NE and their receptors were highly expressed in islet and rapidly regulated different hormones secretion. Phosphorylation is considered an important posttranslational modification in islet innervation and it was identified by quantitative proteomic and phosphoproteomic analyses in this study. The phosphorylated islet proteins were found involved in many biological and pathological processes, such as synaptic signalling transduction, calcium channel opening and insulin signalling pathway. Then, the kinases were predicted by motif analysis and further screened and verified by kinase-specific siRNAs in different islet cell lines (αTC1-6, Min6 and TGP52). After functional verification, Ksr2 and Pkacb were considered the key kinases of ACh and NE in insulin secretion, and Cadps, Mlxipl and Pdcd4 were the substrates of these kinases measured by immunofluorescence co-staining. Then, the decreased expression of receptors, kinases and substrates of ACh and NE were found in diabetic mice and the aberrant rhythm in insulin secretion could be improved by combined interventions on key receptors (M3 (pilocarpine) or α2a (guanfacine)) and kinases (Ksr2 or Pkacb). Abnormal innervation was closely associated with the degree of islet dysfunction in diabetic mice and the aberrant rhythm in insulin secretion could be ameliorated significantly after intervention with key receptors and kinases in the early stage of diabetes mellitus, which may provide a promising therapeutic strategy for diabetes mellitus in the future. Show less
📄 PDF DOI: 10.1002/ctm2.890
MLXIPL

A Novel

Y Peng, J Xu, Y Wang +7 more · 2022 · Balkan journal of medical genetics : BJMG · added 2026-04-24
Cardiomyopathies are a heterogeneous group of diseases predominantly affecting the heart muscle and often lead to progressive heart failure-related disability or cardiovascular death. Hypertrophic car Show more
Cardiomyopathies are a heterogeneous group of diseases predominantly affecting the heart muscle and often lead to progressive heart failure-related disability or cardiovascular death. Hypertrophic cardiomyopathy (HCM) is a cardiac muscle disorder mostly caused by the mutations in genes encoding cardiac sarcomere. Germ-line mutations in Show less
📄 PDF DOI: 10.2478/bjmg-2022-0002
MYBPC3
Yaxun Sun, Jingjun Zhou, Hongkun Wang +5 more · 2022 · Stem cell research · Elsevier · added 2026-04-24
Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease characterized by left ventricular hypertrophy and a high risk of sudden death. In this study, a skin biopsy was obtained from a Show more
Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease characterized by left ventricular hypertrophy and a high risk of sudden death. In this study, a skin biopsy was obtained from a HCM patient harboring a heterozygous missense mutation (c.3764C>A; p.A1225D) in the myosin binding protein C3 (MYBPC3) gene. The isolated fibroblasts were reprogrammed using non-integrated Sendai viral method to establish the patient-specific induced pluripotent stem cell (iPSC) line. The established iPSC line displayed normal morphology and karyotype, expressed pluripotency markers, and can differentiate into three germ layers in vivo. Show less
no PDF DOI: 10.1016/j.scr.2022.102898
MYBPC3
Xin Huang, Kai-Jie Zhang, Jun-Jie Jiang +3 more · 2022 · Frontiers in endocrinology · Frontiers · added 2026-04-24
Type 2 diabetes (T2D) patients with SARS-CoV-2 infection hospitalized develop an acute cardiovascular syndrome. It is urgent to elucidate underlying mechanisms associated with the acute cardiac injury Show more
Type 2 diabetes (T2D) patients with SARS-CoV-2 infection hospitalized develop an acute cardiovascular syndrome. It is urgent to elucidate underlying mechanisms associated with the acute cardiac injury in T2D hearts. We performed bioinformatic analysis on the expression profiles of public datasets to identify the pathogenic and prognostic genes in T2D hearts. Cardiac RNA-sequencing datasets from Show less
📄 PDF DOI: 10.3389/fendo.2022.801260
MYBPC3
Yu Zhang, Yuming Zhu, Mo Zhang +9 more · 2022 · European heart journal. Quality of care & clinical outcomes · Oxford University Press · added 2026-04-24
In the clinical practice, the right ventricular (RV) manifestations have received less attention in hypertrophic cardiomyopathy (HCM). This paper aimed to evaluate the risk prediction value and geneti Show more
In the clinical practice, the right ventricular (RV) manifestations have received less attention in hypertrophic cardiomyopathy (HCM). This paper aimed to evaluate the risk prediction value and genetic characteristics of RV involvement in HCM patients. A total of 893 patients with HCM were recruited. RV hypertrophy, RV obstruction, and RV late gadolinium enhancement were evaluated by echocardiography and/or cardiac magnetic resonance. Patients with any of the above structural abnormalities were identified as having RV involvement. All patients were followed with a median follow-up time of 3.0 years. The primary endpoint was cardiovascular death; the secondary endpoints were all-cause death and heart failure (HF)-related death. Survival analyses were conducted to evaluate the associations between RV involvement and the endpoints. Genetic testing was performed on 669 patients. RV involvement was recognized in 114 of 893 patients (12.8%). Survival analyses demonstrated that RV involvement was an independent risk factor for cardiovascular death (P = 0.002), all-cause death (P = 0.011), and HF-related death (P = 0.004). These outcome results were then confirmed by a sensitivity analysis. Genetic testing revealed a higher frequency of genotype-positive in patients with RV involvement (57.0% vs. 31.0%, P < 0.001), and the P/LP variants of MYBPC3 were more frequently identified in patients with RV involvement (30.4% vs. 12.0%, P < 0.001). Logistic analyses indicated the independent correlation between RV involvement and these genetic factors. RV involvement was an independent risk factor for cardiovascular death, all-cause death and HF-related death in HCM patients. Genetic factors might contribute to RV involvement in HCM. Show less
no PDF DOI: 10.1093/ehjqcco/qcac008
MYBPC3
Peng Shi, Xiaoyu Ren, Jie Meng +14 more · 2022 · Nature communications · Nature · added 2026-04-24
The folded mitochondria inner membrane-cristae is the structural foundation for oxidative phosphorylation (OXPHOS) and energy production. By mechanically simulating mitochondria morphogenesis, we spec Show more
The folded mitochondria inner membrane-cristae is the structural foundation for oxidative phosphorylation (OXPHOS) and energy production. By mechanically simulating mitochondria morphogenesis, we speculate that efficient sculpting of the cristae is organelle non-autonomous. It has long been inferred that folding requires buckling in living systems. However, the tethering force for cristae formation and regulation has not been identified. Combining electron tomography, proteomics strategies, super resolution live cell imaging and mathematical modeling, we reveal that the mitochondria localized actin motor-myosin 19 (Myo19) is critical for maintaining cristae structure, by associating with the SAM-MICOS super complex. We discover that depletion of Myo19 or disruption of its motor activity leads to altered mitochondria membrane potential and decreased OXPHOS. We propose that Myo19 may act as a mechanical tether for effective ridging of the mitochondria cristae, thus sustaining the energy homeostasis essential for various cellular functions. Show less
no PDF DOI: 10.1038/s41467-022-30431-3
MYO19
Zhikun Zhan, Fahong Dai, Tao Zhang +6 more · 2022 · Pharmacological research · Elsevier · added 2026-04-24
Hyperbilirubinemia is a serious hazard to human health due to its neurotoxicity and lethality. So far, successful therapy for hyperbilirubinemia with fewer side effects is still lacking. In this study Show more
Hyperbilirubinemia is a serious hazard to human health due to its neurotoxicity and lethality. So far, successful therapy for hyperbilirubinemia with fewer side effects is still lacking. In this study, we aimed to clarify the effects of oridonin (Ori), an active diterpenoid extracted from Rabdosia rubescens, on hyperbilirubinemia and revealed the underlying molecular mechanism in vivo and in vitro. Here, we showed that liver X receptor alpha (LXRα) deletion eliminated the protective effect of Ori on phenylhydrazine hydrochloride-induced hyperbilirubinemia mice, indicating that LXRα acted as a key target for Ori treatment of hyperbilirubinemia. Ori significantly increased the expression of LXRα and UDP-glucuronosyltransferase 1A1 (UGT1A1) in the liver of wild-type (WT) mice, which were lost in LXRα Show less
no PDF DOI: 10.1016/j.phrs.2022.106188
NR1H3
Ziyu Liang, Shaomei Tang, Rongquan He +3 more · 2022 · Bioengineered · Taylor & Francis · added 2026-04-24
Accumulating evidence indicates that abnormally expressed microRNAs (miRNAs, miRs) contribute to cancer progression. Nonetheless, the role of miR-30e-5p in pancreatic cancer (PCa) remains unclear. In Show more
Accumulating evidence indicates that abnormally expressed microRNAs (miRNAs, miRs) contribute to cancer progression. Nonetheless, the role of miR-30e-5p in pancreatic cancer (PCa) remains unclear. In this study, using quantitative real-time polymerase chain reaction analysis, we found that miR-30e-5p expression was downregulated in human PCa tissues compared with that in normal para-cancerous tissues. After transfecting with miR-30e-5p inhibitors, miR-30e-5p mimics, or empty vectors in the BxPC-3 and PANC-1 cells, respectively, the experiments revealed that the upregulation of miR-30e-5p expression inhibited cell growth, invasion, migration and epithelial-mesenchymal transition (EMT), and promoted apoptosis, while miR-30e-5p downregulation had the opposite effects. RNA sequencing of miR-30e-5p inhibitor-, miR-30e-5p mimic-, and the negative control (NC)-treated groups revealed that miR-30e-5p may affect epithelial cell differentiation, cell growth and death. Next, the snail family transcriptional repressor 1 (SNAI1) was predicted and verified as the target gene of miR-30e-5p using bioinformatics analysis and luciferase assays. SNAI1 expression levels were decreased in the PCa cells transfected with miR-30e-5p mimics, whereas the opposite was observed in the cells transfected with miR-30e-5p inhibitors. Subsequently, PCa cells were transfected with a vector overexpressing SNAI1 (OE-SNAI1) and miR-30e-5p mimics, miR-30e-5p inhibitors, or empty vectors. Compared with that in the OE-SNAI1 + miR-30e-5p NC group, transfection with OE-SNAI1 + miR-30e-5p mimics inhibited the PCa cell growth, migration, and increased apoptosis, whereas transfection with OE-SNAI1 + miR-30e-5p inhibitors had the opposite effects. In conclusion, miR-30e-5p potentially inhibits PCa cell proliferation, migration, and invasion via the SNAI1/EMT axis. Show less
no PDF DOI: 10.1080/21655979.2022.2050880
SNAI1
Shengying Jiang, Xiaoli Xie, Huiqing Jiang · 2022 · Translational cancer research · added 2026-04-24
Colorectal cancer (CRC) is a malignant tumor with high morbidity and mortality, but there is still no recognized prognostic prediction model to better predict and intervene its prognosis. Our aim is t Show more
Colorectal cancer (CRC) is a malignant tumor with high morbidity and mortality, but there is still no recognized prognostic prediction model to better predict and intervene its prognosis. Our aim is to establish a novel microRNA (miRNA) signature and identify hub target genes for simply and accurately predicting survival risk for CRC patients and to provide therapeutic targets. The miRNA expression profiles along with clinical data of 512 CRC patients were downloaded from the Cancer Genome Atlas (TCGA) database and randomly divided into training set and validation set. The signature was generated from the training set after a series of Cox regression analyses, including least absolute shrinkage and selectionator operator (LASSO)-Cox regression, and verified in the test set and the whole set. Furthermore, the signature was compared with clinical risk factors. Interaction network of target genes of the seven micoRNAs was established. Functional enrichment analysis was performed to reveal the biological processes and pathways. GEPIA2 was used for prognostic analysis. A 7-micoRNA prognostic signature was generated from the training set with the areas under the receiver operating characteristic (ROC) curve (AUC) of 5-year survival rate was 0.889. Its performance was well verified both in the test set and the entire set by Kaplan-Meier analysis (P value <0.05). Further analysis demonstrated that the signature was an independent prognostic risk factor for CRC patients and its predictive ability was superior to age and tumor-node-metastasis (TNM) stage. Interaction network found two major gene modules, and they might be involved in the activation of PI3K-Akt-mTOR and p53 signaling pathways, which related to epidermal growth factor receptor (EGFR) resistance. The GEPIA2 revealed that CDKN1A, eIF4E and SNAI1 were associated with CRC prognosis. Our study demonstrated the potential of this novel 7-micoRNA signature to independently predict overall survival in patients with CRC and provided potential therapeutic targets. Show less
no PDF DOI: 10.21037/tcr-21-1992
SNAI1
Wei Xie, Qiwei Jiang, Xueji Wu +9 more · 2022 · Cell death and differentiation · Nature · added 2026-04-24
IKBKE, a non-canonical inflammatory kinase, is frequently amplified or activated, and plays predominantly oncogenic roles in human cancers, especially in breast cancer. However, the potential function Show more
IKBKE, a non-canonical inflammatory kinase, is frequently amplified or activated, and plays predominantly oncogenic roles in human cancers, especially in breast cancer. However, the potential function and underlying mechanism of IKBKE contributing to breast cancer metastasis remain largely elusive. Here, we report that depletion of Ikbke markedly decreases polyoma virus middle T antigen (PyVMT)-induced mouse mammary tumorigenesis and subsequent lung metastasis. Biologically, ectopic expression of IKBKE accelerates, whereas depletion of IKBKE attenuates breast cancer invasiveness and migration in vitro and tumor metastasis in vivo. Mechanistically, IKBKE tightly controls the stability of transcriptional factor Snail in different layers, in particular by directly phosphorylating Snail, which markedly blocks the E3 ligase β-TRCP1-mediated Snail degradation, resulting in breast cancer epithelial-mesenchymal transition (EMT) and metastasis. These findings together reveal a novel oncogenic function of IKBKE in promoting breast cancer metastasis by governing Snail abundance, and highlight the potential of targeting IKBKE for metastatic breast cancer therapies. Show less
no PDF DOI: 10.1038/s41418-022-00940-1
SNAI1
Yunfei Wen, Anca Chelariu-Raicu, Sujanitha Umamaheswaran +12 more · 2022 · Cell reports · Elsevier · added 2026-04-24
Anti-angiogenic therapies, such as anti-VEGF antibodies (AVAs), have shown promise in clinical settings. However, adaptive resistance to such therapies occurs frequently. We use orthotopic ovarian can Show more
Anti-angiogenic therapies, such as anti-VEGF antibodies (AVAs), have shown promise in clinical settings. However, adaptive resistance to such therapies occurs frequently. We use orthotopic ovarian cancer models with AVA-adaptive resistance to investigate the underlying mechanisms. Genomic profiling of AVA-resistant tumors guides us to endothelial p130cas. We find that bevacizumab induces cleavage of VEGFR2 in endothelial cells by caspase-10 and that VEGFR2 fragments internalize into the nucleus and autophagosomes. Nuclear VEGFR2 and p130cas fragments, together with TNKS1BP1 (tankyrase-1-binding protein), initiate endothelial cell death. Blockade of autophagy in AVA-resistant endothelial cells retains VEGFR2 at the membrane with bevacizumab treatment. Targeting host p130cas with RGD (Arg-Gly-Asp)-tagged nanoparticles or genomic ablation of vascular p130cas in p130cas Show less
no PDF DOI: 10.1016/j.celrep.2022.110301
TNKS1BP1
Bo Jiang, Xiaozhi Zhao, Wei Chen +13 more · 2022 · Nature communications · Nature · added 2026-04-24
Organotropism during cancer metastasis occurs frequently but the underlying mechanism remains poorly understood. Here, we show that lysosomal protein transmembrane 5 (LAPTM5) promotes lung-specific me Show more
Organotropism during cancer metastasis occurs frequently but the underlying mechanism remains poorly understood. Here, we show that lysosomal protein transmembrane 5 (LAPTM5) promotes lung-specific metastasis in renal cancer. LAPTM5 sustains self-renewal and cancer stem cell-like traits of renal cancer cells by blocking the function of lung-derived bone morphogenetic proteins (BMPs). Mechanistic investigations showed that LAPTM5 recruits WWP2, which binds to the BMP receptor BMPR1A and mediates its lysosomal sorting, ubiquitination and ultimate degradation. BMPR1A expression was restored by the lysosomal inhibitor chloroquine. LAPTM5 expression could also serve as an independent predictor of lung metastasis in renal cancer. Lastly, elevation of LAPTM5 expression in lung metastases is a common phenomenon in multiple cancer types. Our results reveal a molecular mechanism underlying lung-specific metastasis and identify LAPTM5 as a potential therapeutic target for cancers with lung metastasis. Show less
no PDF DOI: 10.1038/s41467-022-31783-6
WWP2
Chongmeng Yang, Jian Pan, Xu Luo +2 more · 2022 · Regenerative medicine · added 2026-04-24
no PDF DOI: 10.2217/rme-2021-0173
WWP2
Hanjie Jiang, Claire Y Chiang, Zan Chen +7 more · 2022 · The Journal of biological chemistry · Elsevier · added 2026-04-24
WWP2 is a HECT E3 ligase that targets protein Lys residues for ubiquitination and is comprised of an N-terminal C2 domain, four central WW domains, and a C-terminal catalytic HECT domain. The peptide Show more
WWP2 is a HECT E3 ligase that targets protein Lys residues for ubiquitination and is comprised of an N-terminal C2 domain, four central WW domains, and a C-terminal catalytic HECT domain. The peptide segment between the middle WW domains, the 2,3-linker, is known to autoinhibit the catalytic domain, and this autoinhibition can be relieved by phosphorylation at Tyr369. Several protein substrates of WWP2 have been identified, including the tumor suppressor lipid phosphatase PTEN, but the full substrate landscape and biological functions of WWP2 remain to be elucidated. Here, we used protein microarray technology and the activated enzyme phosphomimetic mutant WWP2 Show less
no PDF DOI: 10.1016/j.jbc.2022.101854
WWP2